March 14 (Reuters) - All drug manufacturers, including Novo Nordisk NOVOb.CO and Teva Pharmaceuticals TEVA.TA, whose medicines are part of the second round of price talks have agreed to participate in the negotiation process, a federal health agency said on Friday.